세계의 임신 진단 키트 시장 보고서 : 제품별, 테스트 유형별, 최종 사용자별, 지역별(2025-2033년)

The global pregnancy detection kits market size reached USD 1.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.6 Billion by 2033, exhibiting a growth rate (CAGR) of 5.37% during 2025-2033. The increasing demand for self-detecting pregnancy kits, the introduction of advanced product variants, and the rising birth rate represent some of the key factors driving the market.

Pregnancy detection kits are diagnostics devices used for an early indication of pregnancy. They are manufactured using a lateral flow device (LFD) that contains different types of paper engineered with pores of various sizes. They comprise a test strip that consists of a result window, absorbent paper, and sample well and help detect the presence of reproductive hormones, including human chorionic gonadotropin (HCG), in the samples of urine and blood. They are cost-effective, easy to use, reliable, and provide results in a few minutes. Besides this, as they aid in detecting early pregnancy and promote social and emotional well-being, pregnancy detection kits are gaining traction across the globe. At present, product manufacturers are introducing digital pregnancy detection kits with weeks indicator.

Pregnancy Detection Kits Market Trends:

There is an increase in awareness about the availability of pregnancy detection kits. This, couple with the numerous benefits associated with the early detection of the prenatal period, such as focusing on social and emotional well-being, represents one of the major factors strengthening the growth of the market around the world. Moreover, the growing adolescent pregnancy rate, rising birth rate, and the increasing number of unplanned pregnancies are some of the factors influencing the market positively. In addition, the increasing demand for home-based pregnancy detection kits to reduce the number of hospital visits and minimize healthcare expenses is contributing to the market growth. Apart from this, key players are focusing on promotional strategies, such as celebrity endorsements, banner and television advertisements and marketing in movie theaters to propel people for using pregnancy detection kits, thereby increasing their overall sales. Furthermore, the expansion of pharmacies across residential areas is propelling the growth of the market. Besides this, there is a rise in the number of online retail platforms that offer pregnancy detection kits at affordable rates and with easy accessibility through the comforts of the home. This, in confluence with significant growth in the pharmaceutical and e-commerce industries, is creating a positive outlook for the market. Additionally, rapid urbanization, rising global population, and expanding purchasing power of the consumer are driving the sales of pregnancy detection kits across the globe.

Key Market Segmentation:

Product Insights:

• Home Pregnancy Tests (HPT)
• Digital Devices
• Others

Test Type Insights:

• Urine Test for HCG
• Blood Test for HCG
• Others

End User Insights:

• Household
• Gynecology Clinics
• Hospitals

Regional Insights:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for pregnancy detection kits. Some of the factors driving the North America pregnancy detection kits market included increased availability of pregnancy detection kits, high government spending on quality healthcare, and an increase in unplanned pregnancies.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global pregnancy detection kits market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Axis Medicare, bioMerieux SA (INSTITUT MERIEUX), Cardinal Health Inc., Church & Dwight Co. Inc., Germaine Laboratories Inc, Mankind Pharma, Piramal Enterprises, QuidelOrtho Corporation, Swiss Precision Diagnostics GmbH (Procter & Gamble Company), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

• How has the global pregnancy detection kits market performed so far and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global pregnancy detection kits market?
• What are the key regional markets?
• Which countries represent the most attractive pregnancy detection kits markets?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the test type?
• What is the breakup of the market based on the end user?
• What is the competitive structure of the global pregnancy detection kits market?
• Who are the key players/companies in the global pregnancy detection kits market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Pregnancy Detection Kits Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Home Pregnancy Tests (HPT)
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Digital Devices
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Others
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Test Type

• 7.1 Urine Test for HCG
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Blood Test for HCG
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by End User

• 8.1 Household
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Gynecology Clinics
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Hospitals
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

• 10.1 Overview
• 10.2 Drivers
• 10.3 Restraints
• 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Abbott Laboratories
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Axis Medicare
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 bioMerieux SA (INSTITUT MERIEUX)
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Cardinal Health Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Church & Dwight Co. Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Germaine Laboratories Inc
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Mankind Pharma
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Piramal Enterprises
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
  • 14.3.9 QuidelOrtho Corporation
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Swiss Precision Diagnostics GmbH (Procter & Gamble Company)
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.